Results 71 to 80 of about 32,907 (227)

Machine learning‐based predictive models versus traditional risk scores in hemodialysis patients with comorbid urolithiasis

Precision Medical Sciences, EarlyView.
Machine learning‐based predictive models outperform traditional risk scores in hemodialysis patients with comorbid urolithiasis by capturing nonlinear, dialysis‐specific interactions. These approaches enable more accurate prediction of stone recurrence, sepsis, hospitalization, and mortality, supporting personalized risk stratification and precision ...
Dipal Chaulagain, Muhammad Riaz, Mirza Muhammad Hadeed Khawar, Jawad Hameed, Malik Sohail Riaz   +4 more
wiley   +1 more source

The Effect of Canagliflozin Dose on Renal and Cardiovascular Outcomes in Type 2 Diabetes and High Cardiovascular Risk

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Introduction Pharmacokinetic data suggest a potential dose‐dependent effect of sodium–glucose co‐transporter‐2 (SGLT‐2) inhibitors on surrogate markers of efficacy, but the impact of SGLT‐2 inhibitor dose on renal and cardiovascular outcomes remains uncertain.
Elias John Elenjickal, Frédéric Baroz, Philippe Boileau, Michael A. Tsoukas, Abhinav Sharma, Thomas A. Mavrakanas   +5 more
wiley   +1 more source

Hyperkalemia in the tropics: multiple causes and a not so common presentation—a case report

The Egyptian Journal of Internal Medicine
Background Hyperkalemia is an electrolyte abnormality with potentially life-threatening consequences. But all cases of hyperkalemia need not be symptomatic either.
Abraham M. Ittyachen, Anjely Sukumaran, Ancy Peter, Binitha Baby, Dawn Anthony   +4 more
doaj   +1 more source

Pseudohyperkalemia Revisited: An Updated Review of a Foremost Preanalytical Error of Serum or Plasma Potassium Measurement in the Clinical Laboratory

Nigerian Journal of Medicine
Background: Potassium is one of the most abundant cations in the human body. Increased plasma potassium concentration (hyperkalemia) is one of the most common electrolyte abnormalities in contemporary clinical practice.
Henry Chima Okpara, Emeka Callistus Onyeka Izuchukwu, E. C. Ilechukwu   +2 more
doaj   +1 more source

Hyperkalemia/Hypokalemia

, 2017
Disorders of potassium regulation (hyperkalemia/hypokalemia) are common in clinical medicine. Patients with neuromuscular disorders may develop hyperkalemia in response to inhaled, halogenated anesthetics and/or succinylcholine.
Stephen F. Dierdorf
core   +1 more source

Potassium binders and continuation of renin–angiotensin system inhibitors/mineralocorticoid receptor antagonist in chronic kidney disease and heart failure (the DEMONSTRATE database)

Journal of Internal Medicine, EarlyView.
Abstract Introduction Hyperkalaemia is a serious complication in patients with chronic kidney disease (CKD) and heart failure (HF), often leading to the discontinuation of renin–angiotensin–aldosterone system inhibitors (RAASi; renin‐angiotensin system inhibitors [RASi] and mineralocorticoid receptor antagonists [MRAs]) despite their cardiorenal ...
Hans Furuland, Anders Olof Larsson, Milica Uhde, Kristel Parv, Matilda Almstedt, Thomas Cars, Maria K. Svensson   +6 more
wiley   +1 more source

Outcomes in Older Inpatients with Hyperkalemia: A Follow-up Observational Study

Journal of the Indian Academy of Geriatrics
Objectives: Hyperkalemia is a common electrolyte disturbance encountered in hospitalized older patients secondary to age-related physiological changes in the kidneys, multiple comorbidities, and the burden of multiple medication usage. Metabolic acidosis,
Bharathi Ramesh, Reuben Jerrald Felix, Surekha Viggeswarpu, Antonisamy Belavendra   +3 more
doaj   +1 more source

Optimizing Pneumocystis jirovecii Prophylaxis in Immunocompromised Patients: Defining the Clinical Role of Atovaquone

Transplant Infectious Disease, EarlyView.
In a retrospective cohort study of 149 patients receiving atovaquone for PJP prophylaxis, increased usage was related to broader indications, uptake in new patient groups, difficulty tolerating or accessing alternatives, and longer durations used per patient.
To N. Pham, Kelly A. Cairns, Adithi Ramachandra, Susan G. Poole, Carmela E. Corallo, Bradley J. Gardiner   +5 more
wiley   +1 more source

Severe respiratory acidosis contributing to refractory hyperkalemia: a case series of COVID-19 patients with renal failure [PDF]

Journal of Nephropharmacology
Introduction: Respiratory acidosis (RA) is not known to cause severe hyperkalemia. However, an exception to this general rule was observed in three patients with severe COVID-19 complicated with renal failure in our center.
Nabadwip Pathak, Sunil Kumar Nanda
doaj   +1 more source

Prescriber hyperkalemia knowledge regarding therapeutic decisions related to 10 hyperkalemia-related drugs, as determined by questionnaire.

, 2013
Prescriber hyperkalemia knowledge regarding therapeutic decisions related to 10 hyperkalemia-related drugs, as determined by questionnaire.
Man Young Park (469194), Ju Han Kim (10092), Dukyong Yoon (469192), Martijn J. Schuemie (257191), Inwhee Park (469193), Rae Woong Park (469195)   +5 more
core   +1 more source